P2.02. Pneumonitis Rates Before Versus After Adoption of Immunotherapy Consolidation for Locally Advanced Non-Small Cell Lung Cancer - PDF(Abstract)
Back to course
Pdf Summary
Asset Subtitle
Nikhil Yegya-Raman
Meta Tag
Speaker Nikhil Yegya-Raman
Topic Local-Regional NSCLC: Toxicities of Multimodality Therapy
immunotherapy consolidation
non-small cell lung cancer
ICI era
symptomatic pneumonitis
grade 2 events
lung V20
lung volume
radiation therapy lung dose constraints
Powered By